A Breakthrough Treatment for Parkinson's
Parkinson's is Increasing
Parkinson’s disease affects nearly one million people in the U.S., and this number is expected to rise to 1.2 million by 2030.
Each year, nearly 90,000 people in the U.S. are newly diagnosed with Parkinson’s, a 50% increase from previous estimates. The disease is more common in men than women, and while incidence increases with age, about 4% of cases occur before age 50.
The financial burden of Parkinson’s is significant. In the U.S., the combined direct and indirect costs—including treatment, social security payments, and lost income—amount to nearly $52 billion per year.
Medications alone cost an average of $2,500 per year, while therapeutic surgery can reach $100,000 per person.
Would you like insights on potential treatments or ongoing research efforts?
A New Era for Autoimmune Treatment
Throne Stem Cell Therapy treatment for Parkinson’s has given the patients and improved quality of life.
Previously restricted motion and bodily functions have improved.
The video below shows an adult male treated for Parkinson’s. Notice the manual dexterity, posture, facial expression, and perceived energy after treatment.
The Science Behind SCE Therapy
Through 20 years of rigorous clinical trials, Dr. Zhao’s innovative treatment has proven to regenerate insulin-producing islet b cells and stop autoimmunity at its source.
Using cord blood stem cells, SCE Therapy modulates and resets the immune system, dramatically slowing—or even stopping—disease progression.
Begin your SCE Therapy Treatment
The treatment process starts with contacting us here.